Business Description
HLB Genex Inc
ISIN : KR7187420005
Compare
Compare
Traded in other countries / regions
187420.Korea Index Membership
KOSDAQ Composite Index IPO Date
2015-05-29Description
HLB Genex Inc, formerly GenoFocus Inc is a high-throughput protein evolution company engaged in the development, manufacture, and distribution of enzymes like Lactazyme, chitizyme, and lipase. It develops enzyme solutions for specialty food, eco-friendly processes, biopharmaceuticals, cosmeceuticals, and agriculture.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.26 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 1.73 | |||||
| Debt-to-EBITDA | 4.57 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 1.12 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.8 | |||||
| 3-Year EPS without NRI Growth Rate | 9.6 | |||||
| 3-Year FCF Growth Rate | 30.9 | |||||
| 3-Year Book Growth Rate | -18.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.71 | |||||
| 9-Day RSI | 35.92 | |||||
| 14-Day RSI | 38.61 | |||||
| 3-1 Month Momentum % | 12.72 | |||||
| 6-1 Month Momentum % | 31.75 | |||||
| 12-1 Month Momentum % | 19.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.62 | |||||
| Quick Ratio | 0.48 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 99.51 | |||||
| Days Sales Outstanding | 67.34 | |||||
| Days Payable | 12.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | 24.19 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.48 | |||||
| Operating Margin % | -3.36 | |||||
| Net Margin % | 3 | |||||
| FCF Margin % | 3.56 | |||||
| ROE % | 4.7 | |||||
| ROA % | 1.18 | |||||
| ROIC % | -0.91 | |||||
| 3-Year ROIIC % | -64.95 | |||||
| ROC (Joel Greenblatt) % | 17.7 | |||||
| ROCE % | 23.37 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 82.94 | |||||
| PE Ratio without NRI | 46.19 | |||||
| PS Ratio | 2.79 | |||||
| PB Ratio | 4.03 | |||||
| Price-to-Tangible-Book | 4.42 | |||||
| Price-to-Free-Cash-Flow | 76.23 | |||||
| Price-to-Operating-Cash-Flow | 52.74 | |||||
| EV-to-EBIT | 15.63 | |||||
| EV-to-EBITDA | 14.73 | |||||
| EV-to-Revenue | 3.98 | |||||
| EV-to-FCF | 111.71 | |||||
| Price-to-GF-Value | 0.72 | |||||
| Price-to-Graham-Number | 3.01 | |||||
| Earnings Yield (Greenblatt) % | 6.4 | |||||
| FCF Yield % | 1.21 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HLB Genex Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 34,833.812 | ||
| EPS (TTM) (â‚©) | 51 | ||
| Beta | 0.41 | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.23 | ||
| Volatility % | 60.67 | ||
| 14-Day RSI | 38.61 | ||
| 14-Day ATR (â‚©) | 185.087702 | ||
| 20-Day SMA (â‚©) | 4410.5 | ||
| 12-1 Month Momentum % | 19.35 | ||
| 52-Week Range (â‚©) | 2880 - 5930 | ||
| Shares Outstanding (Mil) | 24.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HLB Genex Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HLB Genex Inc Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
HLB Genex Inc Frequently Asked Questions
What is HLB Genex Inc(XKRX:187420)'s stock price today?
The current price of XKRX:187420 is â‚©4230.00. The 52 week high of XKRX:187420 is â‚©5930.00 and 52 week low is â‚©2880.00.
When is next earnings date of HLB Genex Inc(XKRX:187420)?
The next earnings date of HLB Genex Inc(XKRX:187420) is .
Does HLB Genex Inc(XKRX:187420) pay dividends? If so, how much?
HLB Genex Inc(XKRX:187420) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers